Marketing-authorisation holder · Canada
Leo Pharma Inc
50 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
50 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 50
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADTRALZA300 mg / 2 ml · Solution | Tralokinumab | Canada | Marketed | 2024 |
| ADTRALZA150 mg / ml · Solution | Tralokinumab | Canada | Marketed | 2022 |
| ANZUPGO20 mg / g · Cream | Delgocitinib | Canada | Marketed | 2025 |
| DOVOBET GEL0.5 mg / g + 50 mcg / g · Gel | Betamethasone, Calcipotriol | Canada | Marketed | 2009 |
| DOVOBET OINTMENT0.5 mg / g + 50 mcg / g · Ointment | Betamethasone, Calcipotriol | Canada | Marketed | 2001 |
| DOVONEX50 mcg / g · Ointment | Calcipotriol | Canada | Marketed | 1992 |
| ENSTILAR0.5 mg / g + 50 mcg / g · Aerosol (Foam) | Betamethasone, Calcipotriol | Canada | Marketed | 2016 |
| FINACEA15 % / w/w · Gel | Azelaic acid | Canada | Marketed | 2010 |
| FUCIBET0.1 % / w/w + 2 % / w/w · Cream | Betamethasone, Fusidic acid | Canada | Marketed | 2018 |
| FUCIDIN CREAM 2%2 % · Cream | Fusidic acid | Canada | Marketed | 1984 |
| FUCIDIN H2 % + 1 % · Cream | Fusidic acid, Hydrocortisone | Canada | Marketed | 1998 |
| FUCIDIN OINTMENT 2%2 % · Ointment | Fusidic acid | Canada | Marketed | 1984 |
| HEPARIN LEO 100UNIT/ML100 unit / ml · Solution | Heparin | Canada | Marketed | 1984 |
| HEPARIN LEO INJ 1000UNIT/ML1000 unit / ml · Solution | Heparin | Canada | Marketed | 1987 |
| INNOHEP10000 unit / ml · Solution | Tinzaparin | Canada | Marketed | 2011 |
| INNOHEP20000 unit / ml · Solution | Tinzaparin | Canada | Marketed | 2011 |
| INNOHEP20000 unit / ml · Solution | Tinzaparin | Canada | Marketed | 1997 |
| INNOHEP10000 unit / ml · Solution | Tinzaparin | Canada | Marketed | 2011 |
| INNOHEP20000 unit / ml · Solution | Tinzaparin | Canada | Marketed | 1997 |
| INNOHEP8000 unit / 0.4 ml · Solution | Tinzaparin | Canada | Marketed | 2014 |
| INNOHEP12000 unit / 0.6 ml · Solution | Tinzaparin | Canada | Marketed | 2014 |
| INNOHEP10000 unit / ml · Solution | Tinzaparin | Canada | Marketed | 1995 |
| INNOHEP10000 unit / ml · Solution | Tinzaparin | Canada | Marketed | 1997 |
| INNOHEP20000 unit / ml · Solution | Tinzaparin | Canada | Marketed | 2011 |
| INNOHEP16000 unit / 0.8 ml · Solution | Tinzaparin | Canada | Marketed | 2014 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 50 | 30 | 20 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.